| scholarly article | Q13442814 |
| P50 | author | Donald L Jarvis | Q59033612 |
| P2093 | author name string | Jared J Aumiller | |
| Jason R Hollister | |||
| P2860 | cites work | Sialic acid contents of sindbis virus from vertebrate and mosquito cells. Equivalence of biological and immunological viral properties | Q42979802 |
| Regulation of asparagine-linked oligosaccharide processing. Oligosaccharide processing in Aedes albopictus mosquito cells | Q43032728 | ||
| Isolation and characterization of mosquito cell membrane glycoproteins | Q43034140 | ||
| Steps in the biosynthesis of mosquito cell membrane glycoproteins and the effects of tunicamycin | Q43034143 | ||
| Production of a sialylated N-linked glycoprotein in insect cells | Q43757068 | ||
| Expression of a functional Drosophila melanogaster N-acetylneuraminic acid (Neu5Ac) phosphate synthase gene: evidence for endogenous sialic acid biosynthetic ability in insects | Q43911259 | ||
| A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. | Q50925449 | ||
| Occurrence of sialic acids in Drosophila melanogaster | Q52443762 | ||
| Immediate-early baculovirus vectors for foreign gene expression in transformed or infected insect cells | Q71545092 | ||
| Galactosyl and N-acetylgalactosaminyl homeostasis: a function for mammalian asialoglycoprotein receptors | Q72767093 | ||
| Cloning and expression of the human N-acetylneuraminic acid phosphate synthase gene with 2-keto-3-deoxy-D-glycero- D-galacto-nononic acid biosynthetic ability | Q22253450 | ||
| Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways | Q22254056 | ||
| A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Molecular cloning and functional expression of UDP-N-acetyl-glucosamine 2-epimerase/N-acetylmannosamine kinase | Q24313492 | ||
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Production of Human Beta Interferon in Insect Cells Infected with a Baculovirus Expression Vector | Q24604122 | ||
| Mammalian cytidine 5'-monophosphate N-acetylneuraminic acid synthetase: a nuclear protein with evolutionarily conserved structural motifs | Q24684341 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Assembly of asparagine-linked oligosaccharides | Q28131690 | ||
| The I.M.A.G.E. Consortium: an integrated molecular analysis of genomes and their expression | Q28277156 | ||
| Biosynthesis and subcellular localization of a lepidopteran insect alpha 1,2-mannosidase | Q28354036 | ||
| Glycoproteins from insect cells: sialylated or not? | Q28362910 | ||
| Molecular cloning and expression of the mouse N-acetylneuraminic acid 9-phosphate synthase which does not have deaminoneuraminic acid (KDN) 9-phosphate synthase activity | Q28594602 | ||
| Human and Drosophila UDP-galactose transporters transport UDP-N-acetylgalactosamine in addition to UDP-galactose | Q28610388 | ||
| Constraints on the transport and glycosylation of recombinant IFN-gamma in Chinese hamster ovary and insect cells. | Q30730401 | ||
| Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans. | Q30873680 | ||
| Improved glycosylation of a foreign protein by Tn-5B1-4 cells engineered to express mammalian glycosyltransferases. | Q36815622 | ||
| Isolation and characterization of an alpha 1,2-mannosidase cDNA from the lepidopteran insect cell line Sf9. | Q36860168 | ||
| Expression of biologically active human thyrotropin (hTSH) in a baculovirus system: effect of insect cell glycosylation on hTSH activity in vitro and in vivo | Q38350268 | ||
| Expression and functional characterization of a nucleotide sugar transporter from Drosophila melanogaster: relevance to protein glycosylation in insect cell expression systems. | Q38466741 | ||
| Novel baculovirus expression vectors that provide sialylation of recombinant glycoproteins in lepidopteran insect cells. | Q39603349 | ||
| Evidence for a sialic acid salvaging pathway in lepidopteran insect cells | Q39993642 | ||
| Continuous foreign gene expression in transformed lepidopteran insect cells. | Q40450540 | ||
| Glycosylation of recombinant proteins: problems and prospects | Q40534646 | ||
| Production of a sialylated N-linked glycoprotein in insect cells: role of glycosidases and effect of harvest time on glycosylation | Q40672323 | ||
| Strong and Regulated Expression of Escherichia coli β-Galactosidase in Insect Cells with a Baculovirus Vector | Q40674521 | ||
| Sialylation of N-glycans on the recombinant proteins expressed by a baculovirus-insect cell system under beta-N-acetylglucosaminidase inhibition | Q40763867 | ||
| Mammalian glycosyltransferase expression allows sialoglycoprotein production by baculovirus-infected insect cells | Q40794881 | ||
| Determination of nucleotides and sugar nucleotides involved in protein glycosylation by high-performance anion-exchange chromatography: sugar nucleotide contents in cultured insect cells and mammalian cells | Q40803498 | ||
| Engineering lepidopteran insect cells for sialoglycoprotein production by genetic transformation with mammalian beta 1,4-galactosyltransferase and alpha 2,6-sialyltransferase genes | Q40826999 | ||
| Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels | Q40990270 | ||
| Expression of heterologous proteins in stable insect cell culture | Q40994114 | ||
| Stable expression of mammalian beta 1,4-galactosyltransferase extends the N-glycosylation pathway in insect cells. | Q41041039 | ||
| Glycopinion: biological significance and methods for the analysis of complex carbohydrates of recombinant glycoproteins | Q41272586 | ||
| Use of early baculovirus promoters for continuous expression and efficient processing of foreign gene products in stably transformed lepidopteran cells. | Q41721001 | ||
| N-Glycan processing by a lepidopteran insect alpha1,2-mannosidase. | Q42056798 | ||
| Selective loss of either the epimerase or kinase activity of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase due to site-directed mutagenesis based on sequence alignments | Q42058001 | ||
| Presence of sialic acid in prothoracic glands of Galleria mellonella (Lepidoptera). | Q42062187 | ||
| Oligosaccharide processing in the expression of human plasminogen cDNA by lepidopteran insect (Spodoptera frugiperda) cells | Q42072944 | ||
| The complete DNA sequence of Autographa californica nuclear polyhedrosis virus | Q42598251 | ||
| P4510 | describes a project that uses | SfSWT-1 | Q54953032 |
| SfSWT-3 | Q54953033 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insect | Q1390 |
| cell line | Q21014462 | ||
| P304 | page(s) | 497-507 | |
| P577 | publication date | 2003-02-20 | |
| P1433 | published in | Glycobiology | Q5572596 |
| P1476 | title | A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins | |
| P478 | volume | 13 |
| Q35703121 | A new glycoengineered insect cell line with an inducibly mammalianized protein N-glycosylation pathway. |
| Q33893766 | A new insect cell glycoengineering approach provides baculovirus-inducible glycogene expression and increases human-type glycosylation efficiency |
| Q37573768 | A novel baculovirus vector for the production of nonfucosylated recombinant glycoproteins in insect cells |
| Q91668261 | Anionic and zwitterionic moieties as widespread glycan modifications in non-vertebrates |
| Q34416430 | Baculovirus as versatile vectors for protein expression in insect and mammalian cells |
| Q90667012 | Baculovirus expression systems for production of recombinant proteins in insect and mammalian cells |
| Q37628072 | Baculovirus-insect cell expression systems. |
| Q37980587 | Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks |
| Q35932897 | Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines |
| Q33269616 | Construction and characterization of new piggyBac vectors for constitutive or inducible expression of heterologous gene pairs and the identification of a previously unrecognized activator sequence in piggyBac. |
| Q35146270 | Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production |
| Q97906042 | Engineering orthogonal human O-linked glycoprotein biosynthesis in bacteria |
| Q34785036 | Engineering β1,4-galactosyltransferase I to reduce secretion and enhance N-glycan elongation in insect cells |
| Q38930713 | Enzymatic properties and subtle differences in the substrate specificity of phylogenetically distinct invertebrate N-glycan processing hexosaminidases. |
| Q39993642 | Evidence for a sialic acid salvaging pathway in lepidopteran insect cells |
| Q46990451 | Expression of a functional Drosophila melanogaster CMP-sialic acid synthetase. Differential localization of the Drosophila and human enzymes |
| Q35380617 | Factors affecting recombinant Western equine encephalitis virus glycoprotein production in the baculovirus system |
| Q38013479 | IgG-Fc glycoengineering in non-mammalian expression hosts |
| Q36491777 | Impact of a human CMP-sialic acid transporter on recombinant glycoprotein sialylation in glycoengineered insect cells |
| Q36392872 | Innovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengineered insect cells |
| Q36730542 | Isolation and analysis of a baculovirus vector that supports recombinant glycoprotein sialylation by SfSWT-1 cells cultured in serum-free medium |
| Q24313398 | Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins |
| Q37160231 | Microbial factories for recombinant pharmaceuticals |
| Q41825921 | Minimizing fucosylation in insect cell-derived glycoproteins reduces binding to IgE antibodies from the sera of patients with allergy |
| Q38116835 | Modulation of voltage-gated ion channels by sialylation |
| Q36723748 | Molecular cloning and functional characterization of a Lepidopteran insect beta4-N-acetylgalactosaminyltransferase with broad substrate specificity, a functional role in glycoprotein biosynthesis, and a potential functional role in glycolipid biosyn |
| Q30485683 | MultiBac complexomics |
| Q26830759 | MultiBac turns sweet |
| Q42258662 | N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans |
| Q42755963 | PROTEIN N-GLYCOSYLATION OF GASTROPODS. |
| Q24309073 | Post-translational modifications of recombinant human lysyl oxidase-like 2 (rhLOXL2) secreted from Drosophila S2 cells |
| Q36601827 | Protein N-glycosylation in the baculovirus-insect cell expression system and engineering of insect cells to produce "mammalianized" recombinant glycoproteins. |
| Q36990066 | Protein N-glycosylation in the baculovirus-insect cell system. |
| Q36505675 | Protein glycosylation in diverse cell systems: implications for modification and analysis of recombinant proteins |
| Q34169543 | Re-visiting the endogenous capacity for recombinant glycoprotein sialylation by baculovirus-infected Tn-4h and DpN1 cells |
| Q36601823 | Stably transformed insect cell lines: tools for expression of secreted and membrane-anchored proteins and high-throughput screening platforms for drug and insecticide discovery |
| Q34224840 | SweetBac: a new approach for the production of mammalianised glycoproteins in insect cells. |
| Q92461831 | The Coming Age of Insect Cells for Manufacturing and Development of Protein Therapeutics |
| Q38388047 | The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors |
| Q33548128 | Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production |
| Q36712817 | Vaccine delivery using nanoparticles. |
Search more.